The first mention of the usefulness of YKL-40 testing in patients with colorectal cancer appeared over 25 years ago, when Cintin et al. [40] demonstrated that patients with high preoperative serum YKL-40 concentration had significantly shorter survival. Here, CHI3L1 is linked to colorectal cancer.